Thrombus Growth Under the Influence of Warfarin and After Abrupt Reversal of Its Effects

Murphy, E.A. , Mustard, J.F. , Rowsell , H.C. , and Downie, H.G. : Quantitative studies on the effect of Dicumarol on experimental thrombosis. J. Lab. Clin. Med., 61: 935, 1963.

Cosgriff, S.W. : Chronic anticoagulant therapy in recurrent embolism of cardiac origin. Ann. Intern. Med., 38: 278, 1953.

Keyes, J.W. , Drake, E.H. , and Smith, F.J. : Survival rates after acute myocardial infarction with long-term anticoagulant therapy. Circulation, 14: 254, 1956.

Carter, S.A. , McDevitt, E. , Gatje, B.W. , and Wright, J.S. : Analysis of factors affecting the recurrence of thromboembolism off and on anticoagulant therapy. Amer. J. Med., 25: 43, 1958.

Dinon, L.R. , and VanderVeir, J.B. : Recurrent myocardial infarction after cessation of anticoagulant therapy. Amer. Heart J., 60: 6, 1960.

Zweifler, A.J. , and Boddy, J. : Thrombus propagation in the carotid artery of the rabbit. Arch. Path. (Chicago ), 80: 636, 1965.

Quick, A.J. : On quantitative estimation of prothrombin. Amer. J. Clin. Path., 15: 560, 1945.

Ashwin, J.G. : The effect of drugs on experimental thrombogenesis. In Anticoagulants and Fibrinolysins, Toronto, 1961, edited by R. L. MacMillan and J. F. Mustard , p. 117. The MacMillan Company, New York, 1961.

Dale, D.U. , and Jaques, L.B. : The prevention of experimental thrombosis by dicumarin. Canad. Med. Ass. J., 46: 546, 1942.

Thill, C. , Stafford, W. , Spooner, M. , and Mayer, O.O. : Hemorrhagic agent 3,3'methylenebis (4-hydroxycoumarin). V. Its effect in prevention of experimental thrombosis. Proc. Soc. Exp. Biol. Med., 54: 333, 1943.

Wright, H.P. , Kubik, M. , and Hayden : Recanalization of thrombosed arteries under anticoagulant therapy. Brit. Med. J., 1: 1021, 1953.

Jewell, P. , Pilkington, T. , and Robinson, B. : Heparin and ethyl biscoumacetate in prevention of experimental venous thrombosis . Brit. Med. J., 1: 1013, 1954.

Carey, L.C. , and Williams, R.D. : Comparative effects of dicumarol, tromexan and heparin on thrombus propagation. Ann. Surg., 152: 919, 1960.

Deykin, D. , Wessler, S. , and Reimer, S.M. : Evidence for an antithrombotic effect of dicumarol. Amer. J. Physiol., 199: 1161, 1960.

Rowsell, H.C. , Murphy, E.A. , Glynn , M.F. , and Mustard, J.F. : Adenosine nucleotides, platelets and thrombosis in swine. Blood, 25: 603, 1965.

Sise, H.S. , Moschos, C.B. , Bauthier, J. , and Becker, R. : The risk of interrupting long-term anticoagulant therapy. A rebound hypercoagulable state following hemorrhage. Circulation, 24: 1137, 1961 .

Sevitt, S. , and Innes, M.B. : Evidence against "rebound" thrombosis after stopping oral anticoagulant drugs . Lancet, 2: 974, 1963.

Van Cleve, R. : The rebound phenomenon—fact or fancy? Circulation, 32: 878, 1965.

McGinty, D.A. , Seegers, W.H. , Pfeiffer , C.C. , and Loew, E.R. : Plasma prothrombin concentration in dogs given 31-31-methylenebis (4-hydroxycoumarin) and purified beef prothrombin. Science, 96: 540, 1942.

Lang, G. , Pesic, R. , Bach, D. , and Fontaine, R. : La phase d'hypercoagulation qui suit l'arrit de l'administration de dicoumarol acetate d'ethyle (Tromexan). Presse Med., 69: 104, 1961.

Cosgriff, S.W. : Chronic anticoagulant therapy in recurrent embolism of cardiac origin. Ann. Intern. Med., 38: 282, 1960.

Zweifler, A.J. , and Raccuglia, G. : Heparin retarded thrombelastography . Clin. Res., 8: 282, 1960.

Cotton, R.C. , and Wade, E.G. : Effect of sudden withdrawal of long-term anticoagulant therapy on the heparin resistance and plasma fibrinogen level . Clin. Sci., 26: 337, 1964.

Poller, L. , and Thomson, J. : Evidence for "rebound" hypercoagulability after stopping anticoagulants . Lancet, 2: 62, 1964.

Moschos, C.B. , Sise, H.S. , Becker , R. , and Langer, R. : Study of a rebound hypercoagulable state after coumarin induced hemorrhage. Fed. Proc., 21: 62, 1962.